1498 UPDATED ANALYSES OF A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF FEMPROX®, AN ALPROSTADIL CREAM WITH A NOVEL TRANSDERMAL DELIVERY TECHNOLOGY FOR THE TREATMENT OF FEMALE SEXUAL AROUSAL DISORDER (FSAD)

✍ Scribed by Goldstein, Irwin; Damer, Bassam; Frank, Daniel; Hachica, Mohamed; Fernanco, Ysabella; Schupp, Joachim

• Book ID: 123529697
• Publisher: Lippincott Williams and Wilkins
• Year: 2012
• Tongue: English
• Weight: 58 KB
• Volume: 187
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2012.02.2020